IRIS
AQUARO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.358
EU - Europa 2.430
AS - Asia 1.933
SA - Sud America 320
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 23.092
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.291
SG - Singapore 847
RU - Federazione Russa 503
CN - Cina 406
DE - Germania 314
SE - Svezia 314
BR - Brasile 265
IT - Italia 227
UA - Ucraina 225
HK - Hong Kong 203
IE - Irlanda 167
FR - Francia 163
VN - Vietnam 162
FI - Finlandia 132
GB - Regno Unito 131
PL - Polonia 111
BD - Bangladesh 57
JP - Giappone 56
KR - Corea 50
BE - Belgio 41
CA - Canada 41
IN - India 41
CZ - Repubblica Ceca 35
AR - Argentina 26
NL - Olanda 22
ZA - Sudafrica 21
ID - Indonesia 17
IQ - Iraq 14
TR - Turchia 14
ES - Italia 12
MY - Malesia 10
AT - Austria 9
MX - Messico 9
UZ - Uzbekistan 9
EC - Ecuador 8
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
CO - Colombia 6
LT - Lituania 6
AU - Australia 5
JM - Giamaica 5
RO - Romania 5
CI - Costa d'Avorio 4
KE - Kenya 4
OM - Oman 4
PH - Filippine 4
EU - Europa 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MA - Marocco 3
NP - Nepal 3
PY - Paraguay 3
VE - Venezuela 3
BB - Barbados 2
EG - Egitto 2
GH - Ghana 2
GR - Grecia 2
LB - Libano 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
SA - Arabia Saudita 2
TH - Thailandia 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GI - Gibilterra 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
MF - Saint Martin 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
SC - Seychelles 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 23.092
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.841
Wilmington 4.540
Houston 4.033
Ann Arbor 631
Singapore 514
Fairfield 479
Chandler 418
Ashburn 380
Dallas 286
Moscow 271
Seattle 218
San Jose 215
Jacksonville 208
Hong Kong 202
Cambridge 158
Dublin 154
Beijing 145
Council Bluffs 111
Medford 111
Santa Clara 98
Kraków 92
Helsinki 81
Dearborn 79
New York 76
The Dalles 73
Los Angeles 66
Rome 56
Lawrence 53
Tokyo 49
Ho Chi Minh City 47
Hanoi 44
Brussels 41
Buffalo 37
Mülheim 36
São Paulo 32
Boardman 30
Menlo Park 29
Munich 28
Milan 24
North Bergen 23
Brno 22
Orem 22
Zhengzhou 22
Palo Alto 20
Guangzhou 19
San Diego 19
Lauterbourg 17
Warsaw 16
Chicago 15
London 14
Brooklyn 13
Chennai 13
Columbus 13
Jakarta 13
Phoenix 13
Porto Alegre 13
Redwood City 13
Toronto 13
Denver 12
Marseille 12
Olomouc 12
Kunming 11
Montreal 11
Norwalk 11
Poplar 11
San Mateo 11
Verona 11
Amsterdam 10
Atlanta 10
Johannesburg 10
Haiphong 9
Mountain View 9
Shanghai 9
Stockholm 9
Bengaluru 8
Detroit 8
Hefei 8
Nuremberg 8
Redondo Beach 8
San Francisco 8
West Jordan 8
Dong Ket 7
Frankfurt am Main 7
Jinan 7
Nanjing 7
University Park 7
Beauvais 6
Boston 6
Kuala Lumpur 6
Lappeenranta 6
Washington 6
Ankara 5
Baghdad 5
Changsha 5
Curitiba 5
Da Nang 5
Falls Church 5
Manaus 5
Miami 5
Modena 5
Totale 19.633
Salva come PNG Salva come JPEG
Nome #
1,2,3-TRIAZOLE-[2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-BETA-D-RIBOFURANOSYL]-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOL 2'',2''-DIOXIDE) (TSAO) ANALOGS - SYNTHESIS AND ANTI-HIV-1 ACTIVITY 1.101
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev 528
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4(+) T lymphocytes 526
Therapeutic strategies towards HIV-1 infection in macrophages 516
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 510
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 498
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems 497
Influenza virus A (H5N1): A pandemic risk? 496
Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection 490
Understanding HIV compartments and reservoirs 490
Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: New therapeutic strategies 485
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 484
HIV-1-associated dementia during HAART therapy 480
Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines 476
Effect of maraviroc on non-R5 tropic HIV-1: Refined analysis of subjects from the phase IIb study A4001029 475
Human immunodeficiency virus infection and acquired immunodeficiency syndrome dementia complex: Role of cells of monocyte-macrophage lineage 472
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 469
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1) 463
Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes 461
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 460
Antiviral profile of HIV inhibitors in macrophages: Implications for therapy 458
Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: Evaluation of new 6-desfluoroquinolone derivatives 442
Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals 442
gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure 441
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment 441
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro 436
The contribution of peroxynitrite generation in HIV replication in human primary macrophages 433
Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line 431
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 430
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives 429
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages 420
Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype 419
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 419
Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates 416
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages 415
The role of HIV infection in neurologic injury 415
In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages 414
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 414
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 405
Selected nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL 401
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies 399
Identification of the novel KI polyomavirus in paranasal and lung tissues 389
NeuroAIDS: virological aspects of HIV infection 388
Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells 382
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 360
Effects of amprenavir on HIV-1 maturation, production and infectivity following drug withdrawal in chronically-infected monocytes/macrophages 339
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors 302
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 265
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: New evidence and future perspectives 265
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 232
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir 207
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 192
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 112
Crucial Role of Central Nervous System as a Viral Anatomical Compartment for HIV-1 Infection 104
Evaluation of Natural and Vaccine-Induced Anti-SARS-CoV-2 Immunity: A Comparative Study between Different Groups of Volunteers 100
New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs 93
POTENT ANTIVIRAL ACTIVITY OF NEW GENERATION HIV-1 MATURATION INHIBITORS ON HUMAN PRIMARY CELLS 80
Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages 66
Inhibition of the Protease of Human Immunodeficiency Virus Blocks Replication and Infectivity of the Virus in Chronically Infected Macrophages 56
Totale 23.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.466
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 0 0 0 0 0 0 58
2021/2022729 30 49 87 52 20 75 29 28 79 91 29 160
2022/20231.060 94 87 11 163 88 211 63 63 101 4 65 110
2023/2024434 60 142 19 9 41 55 14 17 4 12 4 57
2024/20251.436 58 288 154 97 55 144 131 107 168 81 95 58
2025/20262.920 205 162 499 254 238 130 355 337 280 230 148 82
Totale 23.229